Effect of yoga as add-on therapy in migraine (CONTAIN) A randomized clinical trial

被引:29
|
作者
Kumar, Anand [1 ]
Bhatia, Rohit [1 ]
Sharma, Gautam [2 ,6 ]
Dhanlika, Dhanlika [3 ]
Vishnubhatla, Sreenivas [4 ]
Singh, Rajesh Kumar [5 ]
Dash, Deepa [5 ]
Tripathi, Manjari [5 ]
Srivastava, M. V. Padma [5 ]
机构
[1] All India Inst Med Sci, Dept Neurol, New Delhi, India
[2] All India Inst Med Sci, Dept Cardiol, New Delhi, India
[3] All India Inst Med Sci, Ctr Integrated Med & Res CIMR, New Delhi, India
[4] All India Inst Med Sci, Dept Biostat, New Delhi, India
[5] All India Inst Med Sci, New Delhi, India
[6] Cardiothorac Ctr, New Delhi, India
关键词
HEADACHES; IMPACT;
D O I
10.1212/WNL.0000000000009473
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective To evaluate the effectiveness of yoga as an adjuvant to conventional medical management on clinical outcomes in patients with migraine. Methods CONTAIN was a prospective, randomized, open-label superiority trial with blinded endpoint assessment carried out at a single tertiary care academic hospital in New Delhi, India. Patients enrolled were aged 18-50 years with a diagnosis of episodic migraine and were randomized into medical and yoga groups (1:1). Randomization was computer-generated with a variable block size and concealed. A predesigned yoga intervention was given for 3 months. Outcomes were recorded by a blinded assessor. The primary endpoint was a decrease in headache frequency, headache intensity, and Headache Impact Test (HIT)-6 score. Secondary outcomes included change in Migraine Disability Assessment (MIDAS) score, pill count, and proportion of headache free patients. Results Between April 2017 and August 2018, 160 patients with episodic migraine were randomly assigned to medical and yoga groups. A total of 114 patients completed the trial. Baseline measures were comparable except for a higher mean headache frequency in the yoga group. Compared to medical therapy, the yoga group showed a significant mean delta value reduction in headache frequency (delta difference 3.53 [95% confidence interval 2.52-4.54];p< 0.0001), headache intensity (1.31 [0.60-2.01];p= 0.0004), HIT score (8.0 [4.78-11.22];p< 0.0001), MIDAS score (7.85 [4.98-10.97];p< 0.0001), and pill count (2.28 [1.06-3.51];p< 0.0003). Conclusion Yoga as an add-on therapy in migraine is superior to medical therapy alone. It may be useful to integrate a cost-effective and safe intervention like yoga into the management of migraine. Clinicaltrials.gov identifier CTRI/2017/03/008041. Classification of evidence This study provides Class III evidence that for patients with episodic migraine, yoga as adjuvant to medical therapy improves headache frequency, intensity, impact, and disability.
引用
收藏
页码:E2203 / E2212
页数:10
相关论文
共 50 条
  • [1] Effect of Yoga as add on Therapy in Migraine (CONTAIN): A Randomized controlled study
    Kumar, Anand
    Bhatia, Rohit
    Sharma, Gautam
    Dhanlika, Dhanlika
    Vishnubhatla, Sreenivas
    Tripathi, Manjari
    Dash, Deepa
    Singh, Rajesh
    Srivastava, M. V. Padma
    NEUROLOGY, 2020, 94 (15)
  • [2] Effect of Yoga as Add on Therapy in Migraine (CONTAIN): A Randomized Controlled Study
    Kumar, A.
    Bhatia, R.
    Sharma, G.
    Dhanlika, D.
    Vishnubhatla, S.
    Tripathi, M.
    Dash, D.
    Singh, R. K.
    HEADACHE, 2019, 59 : 31 - 32
  • [3] Effect of Integrated Yoga as an add-on therapy in adults with clinical depression - A randomized controlled trial
    James Vibin, Anu
    Niharika, Niharika
    Valliappan, Varun
    Lamo, Pasang
    Parajuli, Niranjan
    Jat, Mansingh
    Lama, Sudha
    Agarwal, Aman
    Sagar, Rajesh
    Sharma, Gautam
    INTERNATIONAL JOURNAL OF SOCIAL PSYCHIATRY, 2024, 70 (04) : 709 - 719
  • [4] Yoga as an add-on therapy in the management of migraine
    Sharma, Sachin Kumar
    Singh, Alok
    Telles, Shirley
    Balkrishna, Acharya
    INDIAN JOURNAL OF COMMUNITY MEDICINE, 2020, 45 (02) : 244 - 245
  • [5] Yoga therapy as an add-on treatment in the management of patients with schizophrenia - a randomized controlled trial
    Duraiswamy, G.
    Thirthalli, J.
    Nagendra, H. R.
    Gangadhar, B. N.
    ACTA PSYCHIATRICA SCANDINAVICA, 2007, 116 (03) : 226 - 232
  • [6] Yoga as an add-on treatment in the management of schizophrenia: a randomized controlled trial
    Jagadisha Thirthalli
    Ganesan Duraiswamy
    Shivarama Varambally
    Hongasandra Nagendra
    Bangalore Gangadhar
    Annals of General Psychiatry, 5 (Suppl 1)
  • [7] Is Mirror Neuron System Plastic in Schizophrenia? A Single Blind Randomized Controlled Trial of Add-On Yoga Therapy
    Naik, Shalini
    Govindaraj, Ramajayam
    Mehta, Urvakhsh Meherwan
    Varambally, Shivarama
    Gangadhar, Bangalore N.
    BIOLOGICAL PSYCHIATRY, 2018, 83 (09) : S208 - S208
  • [8] Effect of cotherapy reduction on tolerability of epilepsy add-on therapy: A randomized controlled trial
    Naritoku, DK
    Hulihan, JF
    Schwarzman, LK
    Kamin, M
    Olson, WH
    ANNALS OF PHARMACOTHERAPY, 2005, 39 (03) : 418 - 423
  • [9] Masitinib as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomized clinical trial
    Mora, Jesus S.
    Genge, Angela
    Chio, Adriano
    Estol, Conrado J.
    Chaverri, Delia
    Hernandez, Maria
    Marin, Saul
    Mascias, Javier
    Rodriguez, Gabriel E.
    Povedano, Monica
    Paipa, Andres
    Dominguez, Raul
    Gamez, Josep
    Salvado, Maria
    Lunetta, Christian
    Ballario, Carlos
    Riva, Nilo
    Mandrioli, Jessica
    Moussy, Alain
    Kinet, Jean-Pierre
    Auclair, Christian
    Dubreuil, Patrice
    Arnold, Vincent
    Mansfield, Colin D.
    Hermine, Olivier
    AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 2020, 21 (1-2) : 5 - 14
  • [10] Long-term add-on Yoga therapy offers clinical benefits in major depressive disorder by modulating the complement pathway: A randomized controlled trial
    Subbanna, Manjula
    Talukdar, Pinku Mani
    Abdul, Fazal
    Debnath, Monojit
    Reddy, Preethi V.
    Arasappa, Rashmi
    Venkatasubramanian, Ganesan
    Muralidharan, Kesavan
    Gangadhar, Bangalore N.
    Bhargav, Praerna H.
    Karmani, Sneha
    ASIAN JOURNAL OF PSYCHIATRY, 2021, 66